ATC Abstracts

American Transplant Congress abstracts

2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions
View by Date

Saturday, April 29, 2017

5:30pm-7:30pm
Rates of CMV Infection in Kidney Transplant Recipients Who Received Subtherapeutic Valganciclovir Prophylaxis.

K. Belfield, E. Cohen, M. Malinis, A. Baghban.

Poster Session A: Viral Conundrums  •  Hall D1
5:30pm-7:30pm
Re-Evaluation of Imaging Studies in Patients with Hepatocellular Carcinoma at a Transplant Center Impacts Patient Care.

A. Kardashian, B. Madani, C. Frenette.

Poster Session A: Clinical Science: Liver - Hepatocellular Carcinoma and Cholangiocarcinoma Malignancies  •  Hall D1
5:30pm-7:30pm
Reasons for Ineligibility for Kidney Donation by Race: Gap for Blacks Represented by Modifiable Factors, However Are Big Hurdles to Overcome.

D. Simpson,1 M. Levine,1 S. Amaral.2

Poster Session A: Living Donor Kidney Transplant I  •  Hall D1
5:30pm-7:30pm
Recurrent HCC After Radiofrequency Ablation or Liver Resection Can Be Effectively Treated with Salvage Transplantation.

H. Muaddi,1 D. Al-Adra,1 J. Shaw,1 D. Grant,1 P. Greig,1 I. McGilvray,1 M. Cattral,1 A. Wei,1 C.-A. Moulton,1 J. Kachura,2 R. Beecroft,2 M. Selzner,1 A. Ghanekar,1 S. Gallinger,1 S. Cleary,1 G. Sapisochin.1

Poster Session A: Clinical Science: Liver - Hepatocellular Carcinoma and Cholangiocarcinoma Malignancies  •  Hall D1
5:30pm-7:30pm
Regulatory T Cells Inhibit Plasmablast Formation and IgG Production by Tempering T Follicular Helper Cell Function.

P. Fadakar, C. Macedo, M. Yamada, K. Hadi, D. Metes.

Poster Session A: Antibody Mediated Rejection in Kidney Transplant Recipients I  •  Hall D1
5:30pm-7:30pm
Reliability of Donor Kidney Biopsies from Time of Organ Recovery Compared to Immediate Post-Reperfusion Biopsies.

M. Barrett, A. Prater, E. Farkash, D. Christopher, D. Fritze, N. Matusko, R. Sung, K. Woodside.

Poster Session A: Deceased Donor Issues I: Allocation, KDPI and Recipient Selection  •  Hall D1
5:30pm-7:30pm
Renal Function Outcomes of Hypertensive Living Kidney Donors (HLD) and Recipients of HLD Kidneys: Results of a Case-Control Study.

T. Pesavento,1 A. Diez,1 R. Pelletier,2 U. Nori,1 J. VonVisger.1

Poster Session A: Living Donor Kidney Transplant I  •  Hall D1
5:30pm-7:30pm
Reproducibility of the Cobas CMV Test (cobas CMV) and Clinical Concordance with the Cobas Ampliprep / Cobas TaqMan CMV Test (CAP/CTM CMV).

P. Baum,1 J. Yao,2 A. Butcher,1 P. Hemyari,1 A. Valsamakis,3 S. Young.4

Poster Session A: Viral Conundrums  •  Hall D1
5:30pm-7:30pm
Results of Stem Cell and Renal Transplantation in Patients with End Stage Renal Disease After Plasma Cell Dyscrasias.

C. Moliz,1 B. Redondo,1 M. Molina,1 E. Morales,1 E. Gonzalez,1 J. Cabrera,2 A. Andres.1

Poster Session A: Kidney Complications I  •  Hall D1
5:30pm-7:30pm
Retroactive Application of a New Risk Index for Living Donor Kidney Transplantation (LKDPI) to Renal Transplants in Veracruz, Mexico.

G. Martinez-Mier,1,2 E. Soto-Miranda,1 S. Avila-Pardo,2 L. Budar-Fernandez,1 M. Mendez-Lopez,1 P. Moreno-Ley,1 E. Aguilar-Sandoval,1 G. Coello-Torres,3 F. Diaz-Trueba.3

Poster Session A: Living Donor Kidney Transplant I  •  Hall D1